Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
RPE-J |
Rat retinal pigment epithelial cell line | ATCC CRL-2240 | Rat | sensory organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | Y. Mao et al., Mol. Biol. Cell, Mar 2012; 23: 1104 - 1114 | Link | |
RPE-J |
Rat retinal pigment epithelial cell line | ATCC CRL-2240 | Rat | sensory organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | Y. Dun et al., Free Radical Biology and Medicine, 2013, 65: 1340–1351, doi.org/10.1016/j.freeradbiomed.2013.10.006 | ||
SAN |
Human lymphonodal melanoma cell line | Human | skin | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | S. Romano et al., Clinical and Translational Medicine, 2014, 3:1, doi:10.1186/2001-1326-3-1 | Link | ||
SAN |
Human lymphonodal melanoma cell line | Human | skin | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | S. Romano et al., Cell Death and Disease, 2013, 4: e578, doi:10.1038/cddis.2013.109 | Link | ||
SAN |
Human lymphonodal melanoma cell line | Human | skin | cell line | adherent | siRNA | RNA-Interference | K2 Transfection System | publication | M. Tufano et al., Front. Cell Dev. Biol., 2021, 9: 718947, doi: 10.3389/fcell.2021.718947 | Link | ||
SAN |
Human lymphonodal melanoma cell line | Human | skin | cell line | adherent | siRNA | RNA-Interference | K2 Transfection System | application note | ![]() |
|||
SAN |
Human lymphonodal melanoma cell line | Human | skin | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | F. Albano et al., Biochimie, 2012, DOI: 10.1016/j.biochi.2012.12.012 | |||
SAN |
Human lymphonodal melanoma cell line | Human | skin | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | S. Romano et al., Pigment Cell Melanoma Res., 2015, 28; 442-452; doi: 10.1111/pcmr.12378 | |||
SAN |
Human lymphonodal melanoma cell line | Human | skin | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | S. Romano et al., Pigment Cell Melanoma Res., 2013, 26: 900–911, doi: 10.1111/pcmr.12144 | |||
SAOS-2 |
Human bone osteosarcoma cell line | ATCC HTB-85 | Human | bone | cell line | adherent | siRNA | Metafectene SI | publication | X. Zhou et al., Cell Death and Differentiation, 2015, 22:755-766; doi:10.1038/cdd.2014.167 | Link | ||
SAS |
Human oral squamous cell carcinoma cell line | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | M. Xu et al., PLoS ONE, 2015, 10(3):e0121439; doi:10.1371/journal.pone.0121439 | Link | ||
SAS |
Human oral squamous cell carcinoma cell line | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | M. Xu et al., Journal of Cellular Biochemistry, DOI 10.1002/jcb.26642 | |||
SH-SY5Y |
Human neuroblastoma cell line | ATCC CRL-2266 | Human | bone | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | S. Kim et al., Mol. Cell Biol., 2015, 35:1754-1762; doi:10.1128/MCB.01325-14 | Link | |
SH-SY5Y |
Human neuroblastoma cell line | ATCC CRL-2266 | Human | bone | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | H. Guan et al., Experimental Neurology, 2017, 291: 51-61 | Link | |
SH-SY5Y |
Human neuroblastoma cell line | ATCC CRL-2266 | Human | bone | cell line | adherent | siRNA | cotransfection (plasmid/siRNA) | Metafectene | publication | S. Kim et al., Mol. Cell Biol., 2015, 35:1754-1762; doi:10.1128/MCB.01325-14 | Link | |
SH-SY5Y |
Human neuroblastoma cell line | ATCC CRL-2266 | Human | bone | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | K. Wanget al., Cell Mol. Neurobiol., 2016, 36:603-611; DOI 10.1007/s10571-015-0241-3 | ||
SK-HEP-1 |
Human liver adenocarcinome cell line | ATCC HTB-52 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | C. Ullio et al., J. Lipid Res., Jun 2012; 53: 1134 - 1143 | Link | |
SK-MEL-28 |
Human skin malignant melanoma cell line | ATCC HTB-72 | Human | skin | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | A. D'Anneo et al., J. Cell. Physiol., 2013, 228: 952–967, DOI: 10.1002/jcp.24131 | ||
SK-MEL-3 |
Human skin malignant metastatic melanoma cell line | ATCC HTB-69 | Human | skin | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | S. Romano et al., Pigment Cell Melanoma Res., 2013, 26: 900–911, doi: 10.1111/pcmr.12144 | ||
SK-N-BE(2) |
Human neuroblastoma cell line | ATCC CRL-2271 | Human | brain | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | A. Groß et al., Cancer Res., 2018, DOI: 10.1158/0008-5472.CAN-17-1860 | ||
SK-N-SH |
Human neuroblastoma cell line | ATCC HTB-11 | Human | brain | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | Z. Ping et al., Cell Cycle, 2012, 11: 10, 1999-2005, doi.org/10.4161/cc.20402 | Link | |
SkBr3 |
Human EpCAM-positive breast adenocarcinoma cell line | ATCC HTB-30 | Human | breast | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | N. Golkar et al., Int. J. of Pharmaceutics, 2016, 510: 30-41; doi.org/10.1016/j.ijpharm.2016.06.026 | ||
SkBr3 |
Human EpCAM-positive breast adenocarcinoma cell line | ATCC HTB-30 | Human | breast | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | N. Golkar et al., Data in Brief, 2016, 8:1018-1023; doi.org/10.1016/j.dib.2016.06.064 | Link | |
SKN-SH |
Human neuroblastoma cell line | ATCC HTB-11 | Human | brain | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | C.-C. Yang et al., Mol. Neurobiol., 2017, 54:3476-3491 | ||
SKN-SH |
Human neuroblastoma cell line | ATCC HTB-11 | Human | brain | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | C.-C. Yang et al., Mol. Neurobiol., 2016, 53:5833-5846; DOI 10.1007/s12035-015-9485-7 |